4:31

Anthony Onesto (Burn the Box) critiques traditional employee wellness contests and argues employers should consider covering GLP-1 weight-loss drugs (examples: Ozempic, Wegovy, ZepBound) in health plans. He cites U.S. obesity trends (noting obesity rose from ~30% in 1999–2000 to 41.9% by 2017 and a statement that 1 in 5 adults are considered obese) and market estimates that Ozempic/Wegovy-type drugs could hit $53 billion in sales over the next two years. His proposal: replace or supplement short-term contest-style wellness incentives with access to these medications to achieve both short- and long-term health and cost benefits for employers, while acknowledging cost and side-effect considerations.

Questions this video answers

February 8, 2024

Obesity rates increased from ~30% (1999–2000) to 41.9% (by 2017).

"1 in 5 adults are considered obese."

Expected to hit $53 billion in sales over the next two years.

Chapters

More from Anthony

youtube.com

America's AI Action Plan - HR’s Blueprint for the AI-Ready Workforce

1y ago
youtube.com

A New AI Era for HR Presentations

1y ago
youtube.com

AI's Unspoken HR Strategy: What Every Business Needs to Borrow

1y ago
youtube.com

Simple Guide to Choosing Your AI Tool

1y ago
youtube.com

Why Your Data Isn't Delivering Impact

1y ago
youtube.com

5 Ways AI Revolutionizes Employee Experience

1y ago
youtube.com

AI Adoption Made Easy: How Hackathons Bridge the Gap

1y ago
youtube.com

AI in HR Today - Legal Challenges as a Catalyst for Change

1y ago
youtube.com

AI in HR Today - How AI is Impacting the Workforce

1y ago
youtube.com

AI & HR: Navigating the Velocity of Change

1y ago
youtube.com

Building an AI-Forward Culture: Thrive with AI, Don't Just Adopt It

1y ago
See all content